Liaoning Chengda Biological Co., Ltd. is a high-tech enterprise established in June 2002 based on the international advanced viral vaccine production technology platform. It is the world's largest human rabies vaccine manufacturer. The company focuses on the research and development, production and s...
Vaccine efficacy in field settings is most likely the result of the health status of the host animal, proven duration of immunity of the vaccine used, successful administration, and how the vaccine is transported and conserved [35]. The price per dose of rabies vaccines used in government or ...
Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett SM, Levin R, Meltzer MI, Schaffner W, Cieslak PR (2010) Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices...
Parenteral rabies vaccine, requires dog restraint with potential risk of bites Aggressive or overly shy dogs less likely to be brought to a MSP Depend on owner awareness of MSP clinic, and geographical accessibility Capture vaccinate release vaccination (CVR)*‡ Vaccinators are required to capture...
Nagarajan, T.; Rupprecht, C.; Dessain, S.K.; Rangarajan, P.N.; Thiagarajan, D.; Srinivasan, V.A. Human monoclonal antibody and vaccine approaches to prevent human rabies.Curr. Top. Microbiol. Immunol.2008,317, 67–101. [Google Scholar] [PubMed] ...